Connect your AI

Adaptive Biotechnologies ADPT Earnings yield

Earnings yield at other companies

Guardant HealthGH

-3.6%-1.3pp

Natera, Inc.NTRA

-1.4%0.0pp

Monte Rosa Therapeutics, Inc.GLUE

-9.9%—

GeneDx HoldingsWGS

-4.1%—

VeracyteVCYT

3.4%+2.0pp

Nurix Therapeutics, Inc.NRIX

-18%+0.2pp

Other financials

Income statement

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Calculated from Adaptive Biotechnologies’s reported figures.

net income/market cap=-2.3%

Based on trailing twelve months.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Adaptive Biotechnologies's earnings yield?: Adaptive Biotechnologies (ADPT) reported earnings yield of -2.3% in Q1 2026.
How has Adaptive Biotechnologies's earnings yield changed year-over-year?: Adaptive Biotechnologies's earnings yield increased by 81.9% year-over-year, from -12.8% to -2.3%.
What is the long-term trend for Adaptive Biotechnologies's earnings yield?: Over 5 years (2020 to 2025), Adaptive Biotechnologies's earnings yield has grown at a 6.5% compound annual growth rate (CAGR), from -1.8% to -2.4%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.